| http://www.w3.org/ns/prov#value | - c DNA biomarker technology,??? noted Dr. Howard Urnovitz, CEO of Chronix. ???The Chronix technology has shown early utility in several cancers and in CNS diseases such as multiple sclerosis and BSE. It has the potential to transform disease detection and monitoring, accelerate clinical research, enable development of companion diagnostics and help realize the goal of personalized disease managemen
|
